Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology
Fig 3
(A) Predicted binding poses of levosimendan (blue stick) and co-crystallized ADP (yellow stick) on RIOK1 (ribbon model). (B) Interaction pattern of levosimendan with RIOK1.